Peter Kollár1, Josef Rajchard, Zuzana Balounová, Jiří Pazourek. 1. Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic .
Abstract
CONTEXT: Bryostatins represent an important group of pharmaceutically promising substances. These compounds are produced by commensal microorganisms naturally occurring in marine invertebrates, mainly in bryozoans. The most frequently investigated substance is bryostatin-1, which is a highly oxygenated macrolide with a polyacetate backbone. OBJECTIVE: The aim of this work was to summarize documented preclinical and clinical effects of bryostatin-class compounds. METHODS: A literature search was made of Medline and Web of Science databases in 2012. RESULTS AND CONCLUSION: Our review showed that bryostatins are potent agonists of protein kinase C. In addition to this, their significant antineoplastic activity against several tumor types has also been established and described. Bryostatin's anticancer activity has been proved against various cancer types. Moreover, significant results have been achieved by using bryostatin-1 in combination with other therapies, including combination with vaccine testing. Concerning other important properties that bryostatins possess, their ability to sensitize some resistant cells to chemotherapy agents, or immunoactivity and further stimulating growth of new neural connections, and enhancing effect on long-term memory are worth mentioning. In particular, some new bryostatin analogs could represent potential therapeutic agent for the treatment of cancer and other diseases in future.
CONTEXT: Bryostatins represent an important group of pharmaceutically promising substances. These compounds are produced by commensal microorganisms naturally occurring in marine invertebrates, mainly in bryozoans. The most frequently investigated substance is bryostatin-1, which is a highly oxygenated macrolide with a polyacetate backbone. OBJECTIVE: The aim of this work was to summarize documented preclinical and clinical effects of bryostatin-class compounds. METHODS: A literature search was made of Medline and Web of Science databases in 2012. RESULTS AND CONCLUSION: Our review showed that bryostatins are potent agonists of protein kinase C. In addition to this, their significant antineoplastic activity against several tumor types has also been established and described. Bryostatin's anticancer activity has been proved against various cancer types. Moreover, significant results have been achieved by using bryostatin-1 in combination with other therapies, including combination with vaccine testing. Concerning other important properties that bryostatins possess, their ability to sensitize some resistant cells to chemotherapy agents, or immunoactivity and further stimulating growth of new neural connections, and enhancing effect on long-term memory are worth mentioning. In particular, some new bryostatin analogs could represent potential therapeutic agent for the treatment of cancer and other diseases in future.
Authors: Xiang Rong Tian; Hai Feng Tang; Xiao Lin Tian; Jia Jun Hu; Li Li Huang; Kirk R Gustafson Journal: Future Med Chem Date: 2018-05-23 Impact factor: 3.808
Authors: Randy Chi Fai Cheung; Jack Ho Wong; Wen Liang Pan; Yau Sang Chan; Cui Ming Yin; Xiu Li Dan; He Xiang Wang; Evandro Fei Fang; Sze Kwan Lam; Patrick Hung Kui Ngai; Li Xin Xia; Fang Liu; Xiu Yun Ye; Guo Qing Zhang; Qing Hong Liu; Ou Sha; Peng Lin; Chan Ki; Adnan A Bekhit; Alaa El-Din Bekhit; David Chi Cheong Wan; Xiu Juan Ye; Jiang Xia; Tzi Bun Ng Journal: Appl Microbiol Biotechnol Date: 2014-02-23 Impact factor: 4.813
Authors: Jessica S Kelsey; Christophe Cataisson; Jinqiu Chen; Michelle A Herrmann; Mark E Petersen; David O Baumann; Kevin M McGowan; Stuart H Yuspa; Gary E Keck; Peter M Blumberg Journal: Mol Carcinog Date: 2016-02-09 Impact factor: 4.784